ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

2012 - Master Verification & Validation Planning under U.S. FDA CGMP, ICH Q-series and ISO 13485-14971 Requirements - Webinar By GlobalCompliancePanel

Date2012-03-21

Deadline2012-03-21

Venueonline tra, USA - United States USA - United States

Keywordsonline training,Master Verification, Validation Planning,US FDA, CGMP, ICH Qseries,ISO 13485,14971 Requirements, ICH Q9, 21 CFR Part 11 requirements

Websitehttp://www.globalcompliancepanel.com

Topics/Call fo Papers

Overview: FDA Warning Letters and recent high-profile recalls indicate major cGMP deficiencies in many companies.

One major failing is lack of sufficient or targeted risk-based company-wide V&V planning. Starting with a Master Validation Plan, evaluating its elements against ISO 14971 hazard analysis / risk management, allows development of meaningful product validations. The roles of different V&V protocols. How to employ equipment / process DQs, IQs, OQs, and PQs, or their equivalents per ASTM E2500, against a background of limited company resources (personnel, budget, time). A matrix simplifies "as-product", "in-product", process, and equipment, et al, software V&VT, assuring key FDA requirements are not overlooked. The QMS and 21 CFR Part 11 must be considered.

Why you should attend: Verification and validation requirements have always been part of the US FDA's GMPs. However, with increasing technology, both industry and regulatory agencies expectations have increased. Recent high-profile field problems indicate that V&V activities are not planned or carried out as completely as expected, and may not be fully utilizing the power of current risk management tools, as identified in ISO 14971. The FDA / ICH Q-series provide valuable insights for all regulated industries, not just Pharma. The billions of dollars spent by industry annually for V&V are not providing the product safety or efficacy seemingly promised. For most companies, the fixes are not rocket-science, but proper up-front V&V planning and execution.

Areas Covered in the Session:
Verification or Validation - Recent regulatory expectations
The Master Validation Plan / structure
Product Validation ? how it differs from process / equipment V&V
Process / Equipment / Facility Validation -- FDA's new guidance
When and How to use DQ, IQ, OQ, PQ, or their equivalents
How to use Product Risk Management Tools (per ISO 14971 and ICH Q9)
The 11 key documents for software validation
Incorporating 21 CFR Part 11 requirements
Suggested “test case” formats
Who Will Benefit:
Senior management in Drugs, Devices, Biologics, Dietary Supplements
QA
RA
R&D
Engineering
Production
Operations
Consultants

Price List:
Live : $245.00
Corporate live : $995.00
Recorded : $295.00

webinars-AT-globalcompliancepanel.com
http://www.globalcompliancepanel.com

Phone: 800-447-9407
Fax: 302-288-6884

Last modified: 2012-02-08 21:49:04